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ABSTRACT
Transient increase in cytosolic (Ca2+c ) and mitochondrial Ca2+ (Ca2+m ) are essential elements in the control of manyphysiological processes. However, sustained increases in Ca2+c and Ca2+m may contribute to oxidative stress and celldeath. Several events are related to the increase in Ca2+m , including regulation and activation of a number of Ca2+dependent enzymes, such as phospholipases, proteases and nucleases. Mitochondria and endoplasmic reticulum (ER)
play pivotal roles in the maintenance of intracellular Ca2+ homeostasis and regulation of cell death. Several lines of
evidence have shown that, in the presence of some apoptotic stimuli, the activation of mitochondrial processes may
lead to the release of cytochrome c followed by the activation of caspases, nuclear fragmentation and apoptotic cell
death. The aim of this review was to show how changes in calcium signaling can be related to the apoptotic cell death
induction. Calcium homeostasis was also shown to be an important mechanism involved in neurodegenerative and
aging processes.
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CELL DEATH MECHANISMS
Cell death is one of the primordial events in cellular life
and there are several mechanisms through which cells
achieve death. Both necrotic and apoptotic cell death are
characterized by biochemical and morphological differ-
ences. Necrosis is usually involved in some death stim-
uli related to pathologies and accidental events which are
not well regulated. There are certain features that char-
acterize the two types of cell death, one of them related
to the ATP levels. When the levels of ATP are low, cells
undergo necrosis instead of apoptosis. Frequently, sev-
eral features related to necrosis and apoptosis may occur
simultaneously in the presence of cell death stimuli. This
was described as necrapoptosis which may occur espe-
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cially when cells begin apoptotic and derive to necrotic
cell death (Lemasters et al. 2002).
Apoptosis is one type of Programmed Cell Death
(PCD) which regulates physiological processes involved
in cell maintenance, development, tumor regression,
hormone-induced atrophy, and cell-mediated immunity.
Apoptosis also occurs during certain pathological states,
such as ischemia-reperfusion damage, infarction, neu-
rodegenerative diseases, viral or chemical toxicity, and
can be triggered by activation of either certain death re-
ceptors on the plasma membrane or by cellular stress.
Among some of the elements of the apoptotic cascade
there are the activation of specific cysteine proteases
(caspases); mitochondrial release of death factors, such
as cytochrome c and SmacDiablo and finally the charac-
teristic changes in nuclear morphology and DNA frag-
mentation (Green and Reed 1998).
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There are several ways to trigger apoptosis with dis-
tinct and highly complex pathways. The extrinsic path-
way is triggered by the binding of death molecules to
their receptors, while the intrinsic pathway is activated
by various cellular insults and involves the Bcl-2 fam-
ily of proteins (Youle and Strasser 2008). It has been
shown that, in response to a wide variety of agents and
conditions, Ca2+ signaling could also lead to apoptosis
(Rong and Distelhorst 2008). Figure 1 shows the extrin-
sic and intrinsic signaling pathways that lead to apop-
tosis in mammalian cells (Orrenius et al. 2003).
PROTEINS OF THE BCL-2 FAMILY AND APOPTOSIS
Apoptosis is a natural cell elimination process involved
in a great number of physiological and pathological
events. This process can be regulated by members of the
Bcl-2 family. Bax, a pro-apoptotic member of this fam-
ily, accelerates cell death, while the pro-survival mem-
ber, Bcl-xL can antagonize the pro-apoptotic function ofBax and promote cell survival. Members of the Bcl-
2 family form a group of proteins that play important
roles in the regulation of cell death under both physi-
ological and pathological conditions. Proteins of this
family promote either cell survival, such as Bcl-2 and
Bcl-xL, or cell death, such as Bax and Bid (Smaili etal. 2000, Krajewski et al. 1994). In living cells, Bax
and Bid are predominantly soluble proteins (Hsu et al.
1997). Bcl-2 is associated with membranes of the or-
ganelles, including endoplasmic reticulum (ER), mito-
chondria, and nuclei (Krajewski et al. 1994). Bcl-xLexists in both soluble and membrane-bound forms (Hsu
et al. 1997). During apoptosis, Bcl-2 remains bound to
the membranes, but the cytosolic form of Bax, Bid and
Bcl-xL were found redistributed from the cytosol intomembranes, especially mitochondrial (Hsu et al. 1997,
Li et al. 1998). The mechanisms leading to Bax and
Bcl-xL redistribution are still not known and Bid is be-
lieved to be post-translationally cleaved by caspase-8
leading to Bax transactivation, which is the activation
followed by translocation of the protein (Li et al. 1998).
BAX AS AN APOPTOTIC PROTEIN
Bax was first identified as a Bcl-2 binding partner by
immunoprecipitation (Oltvai et al. 1993). Subsequently,
it was shown that overexpression of Bax can accelerate
cell death in response to various apoptosis stimuli (Yang
and Korsmeyer 1996). Physiologically, Bax plays an
important role in neuronal development and spermato-
genesis. Under pathological conditions such as cere-
bral and cardiac ischemia, upregulation of Bax has been
detected in the afflicted area of the tissues, leading to
the participation of this protein in neuronal and cardio-
myocytic cell death (Krajewski et al. 1999). In certain
cases of human colorectal cancer, mutations were found
in the gene encoding Bax, suggesting that inactivation
of Bax promotes tumorigenesis by enabling the tumor
cells to be less susceptible to cell death (LeBlanc et
al. 2002).
Bax, like other members of the Bcl-2 family, shares
a common feature of having three conserved regions
named BH (Bcl-2 homology) domains 1-3 (Zha et al.
1996). Several lines of evidence show that these domains
can be important for the regulatory functions of these
Bcl-2 family proteins. In addition, Bax and other Bcl-2
family members also possess a hydrophobic segment at
their carboxyl terminal ends, which might be required
for anchoring the protein to the organelles, such as ER
and mitochondria (Zha et al. 1996). In healthy cells,
Bax is predominantly a soluble monomeric protein (Hsu
et al. 1997) despite the C-terminal hydrophobic segment,
which is sequestered inside a hydrophobic cleft (Suzuki
et al. 2000). Upon induction of apoptosis by a variety
of agents, a significant fraction of Bax may translocate
from the cytosol to the membrane fractions, in partic-
ular, the mitochondrial (Hsu et al. 1997, Smaili et al.
2001a). This translocation process appears to involve a
conformational change in Bax leading to the exposure
of its C-terminal hydrophobic domain (Nechushtan et al.
1999). The insertion of Bax into mitochondria causes
the release of cytochrome c and loss of mitochondrial
membrane potential (19m) (Goldstein et al. 2000).Cytochrome c activates caspase-3 leading to the prote-
olysis of the cell, while the loss of 19m correspondsto a decrease in cellular energy production. The pro-
apoptotic activity of Bax, however, can be counteracted
by co-expression with pro-survival factors Bcl-2 and
Bcl-xL, which can block Bax translocation to mitochon-
dria during apoptosis (Smaili et al. 2008).
Several hypotheses were proposed to explain Bax
insertion into mitochondrial membranes, causing the re-
lease of cytochrome c. Three of them were mostly con-
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Fig. 1 – The Extrinsic and Intrinsic Pathways of Apoptosis. The extrinsic pathway is a receptor-dependent mechanism in which the activation of
the death receptors leads to the formation of death-inducible signaling complex (DISC), activation of caspases 8 followed by a cascade of caspases
that will execute cell death. When caspase-8 is activated it may lead to Bid (a BH3 only pro-apoptotic protein) and intrinsic pathway activation. The
intrinsic pathway is activated by the presence of apoptotic stimuli which may cause Bax translocation to mitochondria. Once in the mitochondria,
Bax, together with other pro-apoptotic proteins, activates mechanisms that evoke the release of cytochrome c and other pro-apoptotic factors which
lead to caspase-9, caspase-3 and other caspases activation that will execute cell death (Adapted from Orrenius et al. 2003 Nat Rev Mol Cell Biol
4: 552-565). Besides the release of the pro-apoptotic factors, Bax promotes Ca2+m mobilization as well (Carvalho et al. 2004).
sidered: a) Bax could oligomerize and form pores which
permeabilize the mitochondrial membranes (Antonsson
et al. 2000, Kroemer et al. 2007); b) Bax could interact
with components of the PTP, such as the ANT (Marzo
et al. 1998); c) Bax could interact with other proteins
that promote fission or inhibit fusion and form tempo-
rary channels (Youle and Strasser 2008). In all cases,
the result is the release of cytochrome c and in certain
circumstances this can also lead to the release of calcium
to cytosol as observed in our previous results (Carvalho
et al. 2004). However, the exact mechanism is still a
matter of intense debate (Kroemer et al. 2007). X-ray
crystallographic and solution NMR analyses of the re-
combinant Bcl-xL showed that it shares a high degree ofstructural similarity to the translocation domain of diph-
theria toxin (Muchmore et al. 1996), which can insert
into lipid bilayers, suggesting that Bax may form ion
channels or pores (Schlesinger et al. 1997, Korsmeyer
et al. 2000). Another mechanism proposed is related
to the direct or indirect interaction of Bax with compo-
nents of the permeability transistion pore (PTP), such as
ANT or VDAC channels, which could contribute to the
opening or closure of this megachannel (Kroemer et al.
2007). In addition, others have shown that Bcl-2 fam-
ily proteins may modulate, together with other proteins,
the fission and fusion processes, yielding the formation
of transient channels throughout cytochrome c might be
released. After the release, cytochrome c can interact
with Apaf-1 (Zou et al. 1997) and this complex, in the
presence of dATP, catalyzes the activation of caspases to
induce proteolysis of the cellular constituents (Kroemer
et al. 2007).
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BAX AND MODULATION OF Ca2+ SIGNALING
Recently, it has been shown that Bcl-2 proteins may
regulate and be regulated by the Ca2+C levels, which in-fluence cell death signaling (Scorrano et al. 2003, Car-
valho et al. 2004). Translocation of Bax to mitochon-
dria is associated with a release of cytochrome c from
the mitochondrial intermembrane space (IMS) and a loss
of the mitochondrial membrane potential (19m) (Smailiet al. 2001a). It is well known that mitochondria are
important Ca2+ stores and they are in close relation and
communication with ER (Rizzuto and Pozzan 2006).
The uptake and release of Ca2+ from these organelles
modulate intracellular Ca2+ signaling (Smaili and Rus-
sell 1999, Smaili et al. 2001b). In addition, Ca2+ taken
up by mitochondria contributes to the activation of mi-
tochondrial Ca2+ dehydrogenases and ATP production
(Robb-Gaspers et al. 1998). Interestingly, Bax and other
pro-apoptotic members of the Bcl-2 family were shown
to modulate the ER and mitochondrial Ca2+ stores (Nutt
et al. 2001, Pan et al. 2001). When at the ER level, Bax
may deplete Ca2+ from this store and activate caspase-
12 (Zong et al. 2003) and, when ER Ca2+ stores are
depleted, there is a reduction in Bax-induced apoptotic
cell death (Scorrano et al. 2003). Since the relation be-
tween Ca2+ homeostasis, oxidative stress and apoptotic
cell death is not clear, we have studied in our laboratory
the role of Ca2+ and its mobilization from intracellu-
lar compartments, in the presence of apoptotic induc-
ers, linking it to the modulation by proteins of the Bcl-2
family, such as Bax.
We have first shown that, in Cos-7 cells transfected
and overexpressing GFP-Bax, this protein is visualized
soluble in the cytosol and, upon apoptotic stimuli such
as staurosporine, it translocates to membranes. We have
observed that when associated to mitochondria Bax
induces a loss of 19m (Smaili et al. 2001a). In cellsco-expressing Bax and Bcl-xL, staurosporine was notable to induce neither 19m loss nor Bax translocation(Smaili et al. 2008). In other cell systems, such as
rat astrocytes in primary culture, recombinant protein
Bax (rBax), instead of Bax overexpression, also induced
a loss of 19m in a concentration dependent manner(Carvalho et al. 2004). This effect was shown to be
related to the inhibition of respiratory rates (30–45%)
and a partial release of cytochrome c, with changes in
the mitochondrial morphology (Carvalho et al. 2004).
The loss of 19 was associated with a permeabilization
of mitochondrial membranes, which contributed to the
release of Ca2+m (68% of the maximum Ca2+ content ofthe cell).
In recent studies, we have shown that the pro-apop-
totic protein Bax may also modulate Ca2+ homeosta-
sis in rat cortical astrocytes (A.P. Morales et al., un-
published data). In the absence of apoptosis induction,
Bax overexpression promoted an increase in mitochon-
drial and ER Ca2+ loads, showing a possible role for
Bax apart from its pro-apoptotic action. On the other
hand, we observed that drugs which promote Ca2+c in-crease could differentially induce Bax translocation to
mitochondria. The kinetics of Ca2+c increase appearedto be dependent on the source of Ca2+ pools, originated
from extracellular or intracellular compartments. Ac-
tually, we showed that release of ER Ca2+ store evoked
by different stimuli could selectively induce Bax translo-
cation. This was corroborated by microinjection of IP3which promoted Bax transactivation, supporting the role
of ER-Ca2+ in regulating Bax and cell death activa-
tion (A.P. Morales et al., unpublished data). These find-
ings indicate that the function of Bax and apoptosis is
closely tied not only to cell death induction but also to
Ca2+ homeostasis. It is interesting to note that when we
have evaluated the effect of Bcl-xL on Bax-induced al-terations in mitochondrial respiration and Ca2+ release,
we found that Bcl-xL is able to antagonize Bax-induceddecrease in mitochondrial respiration and the release of
Ca2+m (Teles et al. 2008a). This regulation of Ca2+by Bcl-xL may represent that the modulation of Ca2+homeostasis also contributes to a mechanism by which
this protein promotes cell survival. In Figure 2 we show
a schematic representation of Ca2+ signaling and the
regulation by Bax.
Another interesting relation between Bax and
Ca2+ stores is that, in cells microinjected with rBax,
a Ca2+c wave was observed and this wave was propa-gated from one cell to another. It is possible that the
wave propagation via cell-junctions may lead to the
transmission of cell death signals between cells. Our
results showed that Bax induces mitochondrial altera-
tions that affect Ca2+ homeostasis and signaling. These
changes show an involvement of Ca2+ signals during
apoptosis, which is probably correlated with the pro-
apoptotic activities of Bax.
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cytochrome c
Fig. 2 – Ca2+ homeostasis and regulation of Bax. In resting condition Ca2+ concentration is 1.3 mM and 100 nM at the extracellular and
intracellular spaces, respectively. When metabotropic receptors are stimulated Ca2+c is increased by the release of Ca2+ from intracellular stores,
such as ER and mitochondria. Transient increase in Ca2+c stimulates Ca2+ uptake by mitochondria found in close proximity to ER. In regular
conditions, mammalian cells express low level of Bax which is soluble in the cytosol. Under stress, cells overexpress pro-apoptotic proteins such
as Bax which may translocate from cytosol to the mitochondrial membranes. At the mitochondrial level, Bax may oligomerize and form pores,
interact with the PTP components or interact with other proteins for fission. The results are the release of cytochrome c and calcium to cytosol.
Stimuli that mobilize Ca2+ from intracellular stores (e.g. metabotropic receptor agonists or thapsigargin) may also induce Bax translocation
and increase Bax toxicity. Once in the mitochondria, Bax leads to the permeabilization of mitochondrial membranes leading to the release of
cytochrome c and other factors such as AIF, smacDIABLO which activate pro-caspases and down caspases that execute cell death. Bax can
also release Ca2+m which may amplify cell death signals and accelerate apoptosis (Adapted from Orrenius et al. 2003 Nat Rev Mol Cell Biol 4:
552–565).
CALCIUM SIGNALING AND NEURODEGENERATION
It is well known that, during Ca2+c overload, mitochon-dria and ER may take up Ca2+, which causes Ca2+m ac-cumulation, change in the mitochondrial pH, increase
of the reactive oxygen species (ROS) production, de-
crease or complete loss of 19m and opening of the PTP.Several reports showed that inhibitors of the electron
transport chain, such as Malonate, 1-methyl-phenylpyri-
dinium (MPP+) and 3-nitropropionic acid (3NP), induce
cell injuries and neuronal degeneration in vitro and in
vivo (Brouillet et al. 1993, Smith and Bennett 1997).
The treatment with 3NP, an irreversible inhibitor of the
mitochondrial complex II succinate dehydrogenase, may
cause neuronal death, leading to anatomic and neuro-
chemical changes similar to those present in Hunting-
ton’s disease (HD) patients (Beal et al. 1993, Brouillet
et al. 1995).
The HD is a hereditary autosomal dominant neu-
rodegenerative disorder caused by an expansion of CAG
repeats in chromosome 4 (Gusella et al. 1983). During
its development, patients with HD present motor symp-
toms, psychic disorders and cognitive deficits. HD, as
many neurodegenerative processes, is associated with
changes in Ca2+ homeostasis and ROS production. Be-
cause mitochondria are important for Ca2+ homeosta-
sis and signaling, and are also involved in apoptotic cell
death, there is a special interest in understanding the re-
lation of Ca2+ and cell death signaling with the neuro-
degenerative processes.
In our studies we have also investigated cellular
mechanisms related to mitochondrial dysfunctions in-
duced by 3NP. In addition, we have looked to Ca2+
homeostasis in the brain slices from HD transgenic mice,
a method developed in our laboratory (Smaili et al.
2008). These animals were also used to investigate
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apoptosis and its relation with the levels of bcl-2 and
bax, genes that encode the anti-apoptotic protein Bcl-
2 and the pro-apoptotic protein Bax, respectively. We
showed that 3NP is able to release Ca2+m in mice astro-cytes and, in the presence of PTP inhibitors and antiox-
idants, this effect was inhibited. Thus, inhibition of the
complex II by 3NP is associated with Ca2+m release, in-crease in ROS production and PTP opening. The 3NP
also induced apoptosis in these cells (Rosenstock et al.
2004). In transgenic mice for HD we have observed that
there is a sustained and significant increase in Ca2+c aftera stimulation of brain slices with glutamate (Smaili et
al. 2008), which might be related to the increased levels
of Ca2+ in intracellular stores and with the inability of
mitochondria to uptake high levels of the ion present in
the cytosol. We have also investigated the participation
of gene expression of bax and bcl-2 in tissues from R6/1
transgenic (TGN) mice with different ages (3, 6 and 9
months). The mRNAs expression were investigated and
related to apoptotic cells measured by TUNEL. Results
showed a significantly progressive (from 6 to 9-month-
old) increase in bax mRNA levels in the cortex of TGN
when compared to control mice. There was a decrease
in the bcl-2/bax ratio which was associated with the in-
crease in the number of apoptotic nuclei. It is possible
that the elevation of bax is related to cellular changes
that contribute to neurodegeneration and support the
idea that, in different cell models, the alterations in Ca2+chandling and the levels of the Ca2+ stores may modu-
late important steps of the cell death signaling which can
contribute to cellular degeneration and to apoptotic cell
death induction (Teles et al. 2008b).
CALCIUM STORES, CELL DEATH AND AGING
Aging is a multi-faceted process associated with several
functional and structural deficits, and the brain is one
of the most affected systems by chronic and degener-
ative diseases. Among them, Alzheimer’s and Parkin-
son’s diseases are the most prevalent in the world and
cause the most severely impairments of actions. There-
fore, it is necessary to investigate the age-related risk
factors and the possible mechanisms involved in brain
damage and the future perspectives for protection and
therapeutics. In addition, it is also known that, in neu-
rodegenerative disorders, there are alterations in Ca2+
homeostasis which contribute to cell death. In our pre-
vious work, we have shown that, in different tissues
from senescent rats, there is an increase in Ca2+ con-
tent in the intracellular stores, such as the ER and mi-
tochondria (Lopes et al. 2004, 2006). These data can
be corroborated by a decrease in Ca2+ buffering ca-
pacity, as well as an increase in apoptotic cell death
in different smooth muscle tissues (Lopes et al. 2006,
2007). Recently, we have investigated the alterations in
Ca2+ signaling and the possible involvement with mi-
tochondrial dysfunction and activation of pro-apoptotic
factors. We studied some phenomena concerning the
triad Ca2+-mitochondria-ROS (Toescu and Verkhratsky
2007) and apoptosis in striatum of aged rats. Our results
showed that glutamate evoked a Ca2+ rise which was
greater in slices from aged animals. The evaluation of
the intracellular Ca2+ contents of the ER and mitochon-
dria were increased in this group. Additionally, there
was a reduction in the 19m, an increase in basal ROS
levels and an inhibition of the complex I, which could
be associated with an increased vulnerability (R.P. Ure-
shino et al., unpublished data). As investigated for HD
neurodegenerative process, we have also analyzed the
elements of apoptotic pathway such as Bax and Bcl-2
gene and protein expression. The results showed an in-
crease in bax transcript and a decrease in Bcl-2 protein
which might be associated with the increase in apopto-
sis observed in senescent rats. Altogether, these results
show that in aging, as well as in neurodegeneration,
there are alterations in Ca2+ handling that may affect
the bioenergetic and mitochondrial functions and may
contribute to apoptotic induction and cell death process
(R.P. Ureshino et al., unpublished data).
FUTURE PERSPECTIVES
In the past recent years, several lines of evidence have
shown that calcium signaling is involved in apoptotic
cell death caused by certain stimuli. It is also clear that
members of the Bcl-2 family of proteins may regulate
or be regulated by the levels of calcium at the intracel-
lular stores. Thus, the communication between the two
main organelles that accumulate calcium, ER and mi-
tochondria, may determine and modulate the apoptotic
pathways as well. However, several aspects of this re-
lationship between calcium and cell death signaling are
still unknown and should be a source of investigation by
many researchers. Since in many diseases the levels of
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anti- and pro-apoptotic proteins are altered and these pro-
teins modulate and are modulated by calcium signals, it
will be necessary to further elucidate the exact roles of
Bcl-2 family and calcium homeostasis in cell death.
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RESUMO
Aumentos transientes no cálcio citosólico (Ca2+c ) e mitocon-drial (Ca2+m ) são elementos essenciais no controle de muitosprocessos fisiológicos. No entanto, aumentos sustentados do
Ca2+c e do Ca2+m podem contribuir para o estresse oxidativo ea morte celular. Muitos eventos estão relacionados ao aumento
no Ca2+c , incluindo a regulação e ativação de várias enzimasdependentes de Ca2+ como as fosfolipases, proteases e nuclea-
ses. A mitocôndria e o retículo endoplasmático têm um papel
central na manutenção da homeostase intracellular de Ca2+c ena regulação da morte celular. Várias evidências mostraram
que, na presença de certos estímulos apoptóticos, a ativação dos
processos mitocondriais pode promover a liberação de cito-
cromo c, seguida da ativação de caspases, fragmentação nuclear
e morte celular por apoptose. O objetivo desta revisão é mos-
trar como aumentos na sinalização de Ca2+ podem estar rela-
cionados aos eventos de indução da morte celular apoptótica.
Além disso, evidenciar como a homeostase de Ca2+ pode ser
importante e está envolvida nos mecanismos presentes nos
processos de neurodegeneração e envelhecimento.
Palavras-chave: cálcio, apoptose, Bax, mitocôndrias, retículo
endoplasmático, neurodegeneração e envelhecimento.
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